MERIT and MTI Form Strategic Partnership to Revolutionize Spirometry Data Collection in Clinical Trials
核心洞察
MERIT CRO (搜索) has partnered with Monitored Therapeutics Inc (搜索). to establish a new standard for spirometry endpoints in clinical trials, combining expert oversight with advanced respiratory measurement technology.
The collaboration integrates MTI's GoSpiro (搜索) platform and Lisa avatar-assisted coaching system with MERIT's respiratory expert review capabilities to improve data consistency and repeatability.
The partnership delivers spirometry data through MERIT's EXCELSIOR (搜索) cloud-based platform, providing 24/7 real-time access and full transparency for sponsors and CROs.
MERIT CRO (搜索), Inc. has announced a strategic collaboration with Monitored Therapeutics, Inc. (MTI) to deliver a new standard for spirometry endpoints in clinical trials, addressing long-standing challenges in respiratory data collection. The partnership combines MERIT's deep endpoint expertise with MTI's advanced respiratory measurement technology to provide sponsors with an innovative alternative in the spirometry space.
Technology Integration and Platform Capabilities
Under the collaboration, MTI provides respiratory data capture through its GoSpiro (搜索)® platform, which features Lisa, a real-time avatar-assisted coaching system designed to guide participants through spirometry maneuvers. This technology aims to improve consistency and repeatability of respiratory measurements, addressing key challenges in clinical trial data quality.
MERIT contributes human oversight through respiratory experts who review every spirometry effort to ensure adherence to rigorous scientific and clinical standards. This expert review process is integrated with MTI's technology platform to create a comprehensive quality assurance system.
The partnership utilizes MERIT's EXCELSIOR (搜索)™ secure, cloud-based platform to provide teams with complete visibility into all spirometry data, including both accepted and rejected efforts. The system offers 24/7 real-time access, enabling total transparency and operational efficiency for clinical trial teams.
Industry Impact and Leadership Perspectives
"This partnership accelerates the future of respiratory assessment," said Heather Baumhauer, Chief Operating Officer of MERIT. "Uniting MERIT's expert oversight with MTI's Avatar-Assisted Technology will deliver data clarity and confidence at a scale the industry has never seen. Together, we're setting a new benchmark for how spirometry should be captured, reviewed, and trusted."
Michael Taylor, Chief Clinical Officer and Co-Founder of MTI, emphasized the expanded capabilities the partnership brings to respiratory data collection. "Together, we're combining real-time patient guidance with centralized respiratory expertise and oversight to deliver more consistent, transparent, and reliable spirometry data for sponsors and CROs," Taylor stated.
Comprehensive Service Ecosystem
The collaboration creates what the companies describe as a fully integrated digital-plus-expert ecosystem designed to elevate data integrity, participant experience, and study confidence from end to end. This approach addresses multiple aspects of spirometry data collection, from initial patient guidance through final data validation and delivery.
MERIT operates as a global clinical and preclinical trial endpoint and technology services provider across multiple therapeutic areas, including ophthalmology, respiratory, oncology, and cardiology. The company partners with pharmaceutical and biotech sponsors as well as contract research organizations to deliver endpoint services in multi-regional trials.
MTI focuses specifically on respiratory technology, working to make high-quality lung function testing more accessible, consistent, and easier to deliver across healthcare and clinical research settings. The company's platform connects devices, software, and guided workflows to support respiratory testing both in clinic and at-home environments.